BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20464578)

  • 1. Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials.
    D'Amico D
    Neurol Sci; 2010 Jun; 31 Suppl 1():S23-8. PubMed ID: 20464578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy and safety of topiramate with gabapentin in migraine prophylaxis: randomized open label control trial.
    Zain S; Khan M; Alam R; Zafar I; Ahmed S
    J Pak Med Assoc; 2013 Jan; 63(1):3-7. PubMed ID: 23865122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiepileptic drugs in migraine prophylaxis: state of the art.
    Capuano A; Vollono C; Mei D; Pierguidi L; Ferraro D; Di Trapani G
    Clin Ter; 2004; 155(2-3):79-87. PubMed ID: 15244112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABAergic drugs for the treatment of migraine.
    Puppe A; Limmroth V
    CNS Neurol Disord Drug Targets; 2007 Aug; 6(4):247-50. PubMed ID: 17691980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiepileptic drugs in migraine prevention.
    Mathew NT
    Headache; 2001; 41 Suppl 1():S18-24. PubMed ID: 11903536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study.
    Di Trapani G; Mei D; Marra C; Mazza S; Capuano A
    Clin Ter; 2000; 151(3):145-8. PubMed ID: 10958046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms.
    Calabresi P; Galletti F; Rossi C; Sarchielli P; Cupini LM
    Trends Pharmacol Sci; 2007 Apr; 28(4):188-95. PubMed ID: 17337068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study.
    Bussone G; Usai S; D'Amico D
    Neurol Sci; 2006 May; 27 Suppl 2():S159-63. PubMed ID: 16688622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.
    Shaygannejad V; Janghorbani M; Ghorbani A; Ashtary F; Zakizade N; Nasr V
    Headache; 2006 Apr; 46(4):642-8. PubMed ID: 16643559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.
    He A; Song D; Zhang L; Li C
    J Headache Pain; 2017 Dec; 18(1):26. PubMed ID: 28220376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin for the prophylaxis of episodic migraine in adults.
    Fogleman CD
    Am Fam Physician; 2014 May; 89(9):714-5. PubMed ID: 24784332
    [No Abstract]   [Full Text] [Related]  

  • 13. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.
    Bussone G; Diener HC; Pfeil J; Schwalen S
    Int J Clin Pract; 2005 Aug; 59(8):961-8. PubMed ID: 16033621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.
    Chengappa KN; Gershon S; Levine J
    Bipolar Disord; 2001 Oct; 3(5):215-32. PubMed ID: 11912568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate for migraine prophylaxis.
    Drug Ther Bull; 2006 Aug; 44(8):62-4. PubMed ID: 16903488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiepileptic drugs for the prevention of pediatric migraine].
    Cuvellier JC
    Rev Neurol (Paris); 2009 Dec; 165(12):1002-9. PubMed ID: 19345966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiepileptic drugs in the prophylaxis of migraine, chronic headache forms and cluster headache: a review of their efficacy and tolerability.
    D'Amico D
    Neurol Sci; 2007 May; 28 Suppl 2():S188-97. PubMed ID: 17508169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
    Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of antiepileptic drugs in migraine prophylaxis.
    Adelman JU; Adelman LC; Von Seggern R
    Headache; 2002; 42(10):978-83. PubMed ID: 12453029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.